What is the recommended management for Group B streptococcus (GBS) during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Group B Streptococcus (GBS) During Pregnancy

All pregnant women should undergo universal vaginal-rectal screening for GBS colonization at 36 0/7 to 37 6/7 weeks' gestation, with intrapartum antibiotic prophylaxis administered to all colonized women during labor. 1

Screening Protocol

Timing and Technique

  • Screen between 36 0/7 and 37 6/7 weeks' gestation (updated from the previous 35-37 week window) 1, 2
  • Collect specimens by swabbing the lower vagina (2 cm deep) and rectum (1 cm through the anal sphincter) 2, 3
  • Do not use speculum examination for specimen collection 2
  • Patients may perform their own swabs with appropriate instruction 2, 3
  • Place specimens in non-nutritive transport medium (Amies or Stuart's without charcoal) 2
  • Culture results remain valid for 5 weeks from collection 2

Laboratory Processing

  • Inoculate specimens into selective broth medium, incubate overnight, and subculture onto blood agar 2
  • For penicillin-allergic patients, perform susceptibility testing for clindamycin and erythromycin 2
  • Laboratories should report results to both the ordering provider and anticipated delivery site 2

Indications for Intrapartum Antibiotic Prophylaxis (IAP)

Automatic Indications (No Screening Required)

  • GBS bacteriuria at any concentration during current pregnancy - these women are heavily colonized and at increased risk 2
  • Previous infant with invasive GBS disease - no screening needed, give IAP automatically 2

Screening-Based Indications

  • Positive vaginal-rectal culture at 36-37 weeks 2, 1
  • Unknown GBS status at labor onset with any of these risk factors: 2
    • Delivery at <37 weeks' gestation
    • Membrane rupture ≥18 hours
    • Intrapartum temperature ≥100.4°F (≥38.0°C)

When IAP Is NOT Required

  • Planned cesarean delivery before labor onset with intact membranes at any gestational age, regardless of GBS status 2
  • Negative GBS culture within 5 weeks of delivery, even if risk factors develop 2

Antibiotic Regimens

First-Line Agents

  • Penicillin G: 5 million units IV initial dose, then 2.5-3 million units IV every 4 hours until delivery 2
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery (acceptable alternative) 2

Penicillin Allergy Management

  • For patients with minor/non-anaphylactic allergy: Cefazolin 2 g IV initial dose, then 1 g IV every 8 hours 4
  • For patients at risk of anaphylaxis (history of anaphylaxis, angioedema, respiratory distress, or urticaria to penicillin): 4
    • If GBS susceptible to clindamycin: Clindamycin 900 mg IV every 8 hours
    • If clindamycin-resistant or susceptibility unknown: Vancomycin 1 g IV every 12 hours
  • Consider penicillin allergy skin testing during pregnancy, as confirmation or delabeling provides both short- and long-term health benefits 5, 3

Duration and Timing

  • Adequate prophylaxis requires ≥4 hours of antibiotics before delivery for maximum effectiveness 1
  • Minimum 2 hours of antibiotics reduces GBS vaginal colony counts and decreases clinical neonatal sepsis 1
  • Do not delay necessary obstetric interventions solely to achieve 4 hours of antibiotic administration 1

Preterm Labor Management (<37 Weeks)

Initial Approach

  • Obtain vaginal-rectal swab and start GBS prophylaxis immediately upon admission with signs/symptoms of preterm labor, unless GBS culture performed within preceding 5 weeks 2
  • If patient had positive GBS screen within 5 weeks, give IAP 2
  • If patient had negative GBS screen within 5 weeks, no IAP needed 2

Ongoing Management

  • If true labor confirmed: Continue GBS prophylaxis until delivery 2
  • If not in true labor: Discontinue GBS prophylaxis immediately 2
  • If culture returns negative: Discontinue prophylaxis 2
  • If patient reaches 36-37 weeks without delivering: Repeat vaginal-rectal culture 2

Preterm Premature Rupture of Membranes (PPROM)

  • Obtain vaginal-rectal swab for GBS culture at admission 2
  • Antibiotics given for latency (ampicillin 2 g IV, then 1 g IV every 6 hours for ≥48 hours) are adequate for GBS prophylaxis 2
  • If entering labor with positive GBS status, give GBS prophylaxis 2
  • If entering labor with negative GBS status, no GBS prophylaxis needed but repeat culture if reaches 36-37 weeks 2

Critical Pitfalls to Avoid

  • Do not treat asymptomatic GBS colonization with antibiotics before labor - this does not eliminate carriage or prevent neonatal disease and can cause adverse consequences 2
  • Do not assume previous pregnancy GBS status applies - colonization status changes between pregnancies, requiring screening in each pregnancy 2
  • Do not skip screening for planned cesarean deliveries - labor or membrane rupture can occur before planned surgery, necessitating IAP 2
  • Do not use cervical cultures - only lower vaginal and rectal specimens are appropriate 2
  • Do not withhold perioperative antibiotics for cesarean based on GBS status - these serve different purposes 2

Communication and Documentation

  • Inform all women of their GBS screening results and recommended interventions 2
  • Develop information systems ensuring prenatal culture results are available at delivery site 2
  • Clearly label specimens to indicate pregnancy status and penicillin allergy when applicable 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.